Initial Vmax of an enzyme – substrate interaction is 10 & Km is 5. After adding Drug B Km is 10. Which of the following is false?
First, I need to understand the core concept here. The question is about enzyme inhibition types. The initial Vmax is 10, and Km is 5. After adding Drug B, the Km increases to 10. The key here is to determine what type of inhibitor Drug B is.
The Core Concept would involve enzyme kinetics, specifically the Lineweaver-Burk plot and different types of inhibition. The main types are competitive, non-competitive, and uncompetitive. Competitive inhibitors increase Km but don't affect Vmax. Non-competitive inhibitors lower Vmax without changing Km. Uncompetitive inhibitors lower both Vmax and Km.
The correct answer in this scenario would be that Drug B is a competitive inhibitor. Because the Km increased, which aligns with competitive inhibition where the inhibitor competes with the substrate for the active site, making it seem like the substrate has a lower affinity (higher Km). Vmax remains the same because with enough substrate, the inhibitor can be outcompeted.
Now, looking at the wrong options. If an option states that Drug B is a non-competitive inhibitor, that's incorrect because non-competitive inhibitors don't change Km. If another option says the Vmax changed, that's wrong because Vmax stayed the same. Another wrong option might suggest uncompetitive inhibition, which would affect both Vmax and Km.
The clinical pearl here would be to remember the key effects of each inhibition type on Vmax and Km. Competitive: increased Km, same Vmax. Non-competitive: decreased Vmax, same Km. Uncompetitive: both decreased. Mnemonics like "Competitive K, Non-competitive V" could help.
Putting this all together into the required sections, making sure each part is clear and concise without exceeding the character limit.
**Core Concept**
This question assesses understanding of **enzyme inhibition types** and their effects on **Michaelis-Menten kinetics**. Competitive inhibitors increase **Km** without altering **Vmax**, while non-competitive inhibitors decrease **Vmax** without affecting **Km**. Uncompetitive inhibitors reduce both **Vmax** and **Km**.
**Why the Correct Answer is Right**
Drug B increases **Km** from 5 to 10 but leaves **Vmax** unchanged at 10. This is characteristic of **competitive inhibition**, where the inhibitor competes with the substrate for the active site. The enzyme’s apparent affinity for the substrate decreases (higher **Km**), but maximal velocity remains unchanged because high substrate concentrations can outcompete the inhibitor.
**Why Each Wrong Option is Incorrect**
**Option A:** *If it claimed Drug B is non-competitive* – Non-competitive inhibitors bind allosterically, reducing **Vmax** without altering **Km**. Here, **Vmax** is unchanged, so this is incorrect.
**Option B:** *If it stated Drug B lowers Vmax* – Vmax remains 10, so this contradicts the data.
**Option D:** *If it suggested uncompetitive inhibition* – Uncompetitive inhibitors lower both **Vmax** and **Km**,